ACAD

17.1102.73%
CE

Catherine E. Owen Adams

CEO & Director

Ms. Catherine E. Owen Adams is CEO & Director of ACADIA Pharmaceuticals Inc. from September 23, 2024. She served as Director of OptiNose US, Inc. since July 2020 until September 24, 2024. She serves as Independent Director of Agios Pharmaceuticals, Inc. since June 13, 2023. She has been an Independent Director of OptiNose, Inc. since July 29, 2020. She served as Senior Vice President of Major Markets and General Manager of U.S. at Bristol-Myers Squibb Company, overseen commercial operations for the business in many countries including Japan, Germany, France and others across Europe. She joined BMS in 2019 from Johnson & Johnson, where she served as President of Janssen Immunology North America from 2018 to 2019. Prior to leading Immunology, she was the President of the Infectious Diseases business in the US, responsible for the HIV, RSV, Flu and Hepatitis B pipeline from 2016 to 2018. Prior to that, she worked in various functions and businesses at J&J and led the launches of multiple products in both Europe and the US. She began her career in the pharmaceutical industry in 1992 at AstraZeneca in London as a production support pharmacist. In 2019, in recognition of her efforts as a developer of talent, the Healthcare Businesswomen's Association (HBA) named Owen an HBA Luminary. She obtained a post-graduate diploma in marketing from the University of London. She earned her Bachelor of Science degree in pharmacy from the University of Manchester and completed her registered pharmacy degree and was a member of the Royal Pharmaceutical Society, MRPhs.

公司职务